BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24140269)

  • 1. Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation.
    Frau R; Bini V; Pes R; Pillolla G; Saba P; Devoto P; Bortolato M
    Psychoneuroendocrinology; 2014 Jan; 39():204-213. PubMed ID: 24140269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of 5α-reductase attenuates behavioral effects of D1-, but not D2-like receptor agonists in C57BL/6 mice.
    Frau R; Pillolla G; Bini V; Tambaro S; Devoto P; Bortolato M
    Psychoneuroendocrinology; 2013 Apr; 38(4):542-51. PubMed ID: 22877998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The neurosteroidogenic enzyme 5α-reductase modulates the role of D1 dopamine receptors in rat sensorimotor gating.
    Frau R; Mosher LJ; Bini V; Pillolla G; Pes R; Saba P; Fanni S; Devoto P; Bortolato M
    Psychoneuroendocrinology; 2016 Jan; 63():59-67. PubMed ID: 26415119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 5α-reductase in the nucleus accumbens counters sensorimotor gating deficits induced by dopaminergic activation.
    Devoto P; Frau R; Bini V; Pillolla G; Saba P; Flore G; Corona M; Marrosu F; Bortolato M
    Psychoneuroendocrinology; 2012 Oct; 37(10):1630-45. PubMed ID: 22029952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress.
    Frau R; Abbiati F; Bini V; Casti A; Caruso D; Devoto P; Bortolato M
    Schizophr Res; 2015 Nov; 168(3):640-8. PubMed ID: 25999042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensory and sensorimotor gating-disruptive effects of apomorphine in Sprague Dawley and Long Evans rats.
    Breier MR; Lewis B; Shoemaker JM; Light GA; Swerdlow NR
    Behav Brain Res; 2010 Apr; 208(2):560-5. PubMed ID: 20080128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allopregnanolone is required for prepulse inhibition deficits induced by D
    Mosher LJ; Cadeddu R; Yen S; Staudinger JL; Traccis F; Fowler SC; Maguire JL; Bortolato M
    Psychoneuroendocrinology; 2019 Oct; 108():53-61. PubMed ID: 31228750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats.
    Larrauri JA; Burke DA; Hall BJ; Levin ED
    Psychopharmacology (Berl); 2015 Aug; 232(16):3009-17. PubMed ID: 25912180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural basis for a heritable phenotype: differences in the effects of apomorphine on startle gating and ventral pallidal GABA efflux in male Sprague-Dawley and Long-Evans rats.
    Qu Y; Saint Marie RL; Breier MR; Ko D; Stouffer D; Parsons LH; Swerdlow NR
    Psychopharmacology (Berl); 2009 Dec; 207(2):271-80. PubMed ID: 19756524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat strain differences in the ability to disrupt sensorimotor gating are limited to the dopaminergic system, specific to prepulse inhibition, and unrelated to changes in startle amplitude or nucleus accumbens dopamine receptor sensitivity.
    Kinney GG; Wilkinson LO; Saywell KL; Tricklebank MD
    J Neurosci; 1999 Jul; 19(13):5644-53. PubMed ID: 10377370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating.
    Gresack JE; Seymour PA; Schmidt CJ; Risbrough VB
    Psychopharmacology (Berl); 2014 May; 231(10):2189-97. PubMed ID: 24363077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia.
    Elmer GI; Sydnor J; Guard H; Hercher E; Vogel MW
    Psychopharmacology (Berl); 2004 Jul; 174(2):177-89. PubMed ID: 14985933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heritable differences in the dopaminergic regulation of sensorimotor gating. II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition.
    Swerdlow NR; Shoemaker JM; Auerbach PP; Pitcher L; Goins J; Platten A
    Psychopharmacology (Berl); 2004 Aug; 174(4):452-62. PubMed ID: 15300359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of atomoxetine and methylphenidate on the prepulse inhibition of the acoustic startle response in mice.
    Woo H; Park SJ; Lee Y; Kwon G; Gao Q; Lee HE; Ahn YJ; Shin CY; Cheong JH; Ryu JH
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():206-15. PubMed ID: 24953433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Neurosteroidogenic Enzyme 5α-Reductase Mediates Psychotic-Like Complications of Sleep Deprivation.
    Frau R; Bini V; Soggiu A; Scheggi S; Pardu A; Fanni S; Roncada P; Puligheddu M; Marrosu F; Caruso D; Devoto P; Bortolato M
    Neuropsychopharmacology; 2017 Oct; 42(11):2196-2205. PubMed ID: 28102229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic-like properties of 5-alpha-reductase inhibitors.
    Bortolato M; Frau R; Orrù M; Bourov Y; Marrosu F; Mereu G; Devoto P; Gessa GL
    Neuropsychopharmacology; 2008 Dec; 33(13):3146-56. PubMed ID: 18354385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat strain differences in startle gating-disruptive effects of apomorphine occur with both acoustic and visual prepulses.
    Weber M; Swerdlow NR
    Pharmacol Biochem Behav; 2008 Jan; 88(3):306-11. PubMed ID: 17900675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Convergence and divergence in the neurochemical regulation of prepulse inhibition of startle and N40 suppression in rats.
    Swerdlow NR; Geyer MA; Shoemaker JM; Light GA; Braff DL; Stevens KE; Sharp R; Breier M; Neary A; Auerbach PP
    Neuropsychopharmacology; 2006 Mar; 31(3):506-15. PubMed ID: 16123772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to the dopaminergic regulation of prepulse inhibition in rats: evidence for genetic, but not environmental determinants.
    Swerdlow NR; Platten A; Kim YK; Gaudet I; Shoemaker J; Pitcher L; Auerbach P
    Pharmacol Biochem Behav; 2001; 70(2-3):219-26. PubMed ID: 11701191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A-ring modified steroidal azoles retaining similar potent and slowly reversible CYP17A1 inhibition as abiraterone.
    Garrido M; Peng HM; Yoshimoto FK; Upadhyay SK; Bratoeff E; Auchus RJ
    J Steroid Biochem Mol Biol; 2014 Sep; 143():1-10. PubMed ID: 24508512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.